questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines de tissu nerveux
Neuropeptides
Hormones hypothalamiques
Hormones hypothalamiques hypophysotropes inhibitrices
Hormones hypothalamiques hypophysotropes inhibitrices : Questions médicales fréquentes
Diagnostic
5
Insuffisance hormonale
Tests hormonaux
IRM cérébrale
Hypothalamus
Déséquilibre hormonal
Symptômes
Fonction hypophysaire
Tests de stimulation
Symptômes
5
Carence hormonale
Dépression
Irrégularités menstruelles
Bouffées de chaleur
Retard de croissance
Puberté
Prévention
5
Mode de vie sain
Alimentation équilibrée
Bilan hormonal
Prévention
Stress
Techniques de relaxation
Sommeil
Régulation hormonale
Traitements
5
Médicaments
Agonistes de la dopamine
Thérapie de remplacement
Carence hormonale
Plantes médicinales
Gattilier
Effets secondaires
Nausées
Chirurgie
Tumeur hypophysaire
Complications
5
Infertilité
Troubles métaboliques
Risques cardiovasculaires
Maladies cardiovasculaires
Facteurs de risque
5
Facteurs de risque
Mauvaise alimentation
Surpoids
Équilibre hormonal
Maladies chroniques
Diabète
Antécédents familiaux
Troubles hormonaux
Mode de vie sédentaire
Tabagisme
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hormones hypothalamiques hypophysotropes inhibitrices : Questions médicales les plus fréquentes",
"headline": "Hormones hypothalamiques hypophysotropes inhibitrices : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hormones hypothalamiques hypophysotropes inhibitrices : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-21",
"dateModified": "2026-02-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hormones hypothalamiques hypophysotropes inhibitrices"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hormones hypothalamiques",
"url": "https://questionsmedicales.fr/mesh/D007028",
"about": {
"@type": "MedicalCondition",
"name": "Hormones hypothalamiques",
"code": {
"@type": "MedicalCode",
"code": "D007028",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.631.650.405"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Mélanostatine",
"alternateName": "MSH Release-Inhibiting Hormone",
"url": "https://questionsmedicales.fr/mesh/D009075",
"about": {
"@type": "MedicalCondition",
"name": "Mélanostatine",
"code": {
"@type": "MedicalCode",
"code": "D009075",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.631.650.405.700.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteurs inhibiteurs de la libération de prolactine",
"alternateName": "Prolactin Release-Inhibiting Factors",
"url": "https://questionsmedicales.fr/mesh/D011389",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs inhibiteurs de la libération de prolactine",
"code": {
"@type": "MedicalCode",
"code": "D011389",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.631.650.405.700.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Somatostatine",
"alternateName": "Somatostatin",
"url": "https://questionsmedicales.fr/mesh/D013004",
"about": {
"@type": "MedicalCondition",
"name": "Somatostatine",
"code": {
"@type": "MedicalCode",
"code": "D013004",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.631.650.405.700.875"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Somatostatine-28",
"alternateName": "Somatostatin-28",
"url": "https://questionsmedicales.fr/mesh/D053561",
"about": {
"@type": "MedicalCondition",
"name": "Somatostatine-28",
"code": {
"@type": "MedicalCode",
"code": "D053561",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.631.650.405.700.875.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hormones hypothalamiques hypophysotropes inhibitrices",
"alternateName": "Pituitary Hormone Release Inhibiting Hormones",
"code": {
"@type": "MedicalCode",
"code": "D010905",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Andrew V Schally",
"url": "https://questionsmedicales.fr/author/Andrew%20V%20Schally",
"affiliation": {
"@type": "Organization",
"name": "Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136, USA."
}
},
{
"@type": "Person",
"name": "Renzhi Cai",
"url": "https://questionsmedicales.fr/author/Renzhi%20Cai",
"affiliation": {
"@type": "Organization",
"name": "Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136, USA."
}
},
{
"@type": "Person",
"name": "Nektarios Barabutis",
"url": "https://questionsmedicales.fr/author/Nektarios%20Barabutis",
"affiliation": {
"@type": "Organization",
"name": "School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA."
}
},
{
"@type": "Person",
"name": "Riccarda Granata",
"url": "https://questionsmedicales.fr/author/Riccarda%20Granata",
"affiliation": {
"@type": "Organization",
"name": "Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, 10126 Turin, Italy."
}
},
{
"@type": "Person",
"name": "Iacopo Gesmundo",
"url": "https://questionsmedicales.fr/author/Iacopo%20Gesmundo",
"affiliation": {
"@type": "Organization",
"name": "Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, 10126 Turin, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Functional characterization of growth hormone releasing hormone and its receptor in amphioxus with implication for origin of hypothalamic-pituitary axis.",
"datePublished": "2024-05-26",
"url": "https://questionsmedicales.fr/article/38806133",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ygcen.2024.114560"
}
},
{
"@type": "ScholarlyArticle",
"name": "Corticotropin-Releasing Hormone: A Novel Stimulator of Somatolactin in Teleost Pituitary Cells.",
"datePublished": "2023-12-05",
"url": "https://questionsmedicales.fr/article/38132090",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells12242770"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pituitary Apoplexy Secondary to Gonadotropin-Releasing Hormone Agonist for Breast Cancer.",
"datePublished": "2023-06-28",
"url": "https://questionsmedicales.fr/article/37908581",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1210/jcemcr/luad069"
}
},
{
"@type": "ScholarlyArticle",
"name": "Growth hormone-releasing hormone and cancer.",
"datePublished": "2024-10-18",
"url": "https://questionsmedicales.fr/article/39422787",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11154-024-09919-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ectopic Intrasphenoidal Growth Hormone Releasing Pituitary Adenoma Associated with an Intracranial Aneurysm.",
"datePublished": "2024-06-27",
"url": "https://questionsmedicales.fr/article/39205895",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0042-1757434"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de tissu nerveux",
"item": "https://questionsmedicales.fr/mesh/D009419"
},
{
"@type": "ListItem",
"position": 5,
"name": "Neuropeptides",
"item": "https://questionsmedicales.fr/mesh/D009479"
},
{
"@type": "ListItem",
"position": 6,
"name": "Hormones hypothalamiques",
"item": "https://questionsmedicales.fr/mesh/D007028"
},
{
"@type": "ListItem",
"position": 7,
"name": "Hormones hypothalamiques hypophysotropes inhibitrices",
"item": "https://questionsmedicales.fr/mesh/D010905"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hormones hypothalamiques hypophysotropes inhibitrices - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hormones hypothalamiques hypophysotropes inhibitrices",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hormones hypothalamiques hypophysotropes inhibitrices",
"description": "Comment diagnostiquer une insuffisance hormonale ?\nQuels examens pour évaluer l'hypothalamus ?\nQuels symptômes indiquent un déséquilibre hormonal ?\nComment évaluer la fonction hypophysaire ?\nQuels marqueurs sanguins sont importants ?",
"url": "https://questionsmedicales.fr/mesh/D010905#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hormones hypothalamiques hypophysotropes inhibitrices",
"description": "Quels sont les symptômes d'un excès d'hormones inhibitrices ?\nComment reconnaître une carence hormonale ?\nQuels effets sur le métabolisme ?\nY a-t-il des symptômes spécifiques chez les femmes ?\nQuels symptômes chez les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D010905#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hormones hypothalamiques hypophysotropes inhibitrices",
"description": "Comment prévenir les déséquilibres hormonaux ?\nY a-t-il des examens préventifs recommandés ?\nQuels facteurs de stress à éviter ?\nL'alimentation influence-t-elle les hormones ?\nComment le sommeil affecte-t-il les hormones ?",
"url": "https://questionsmedicales.fr/mesh/D010905#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hormones hypothalamiques hypophysotropes inhibitrices",
"description": "Quels traitements pour l'excès d'hormones inhibitrices ?\nComment traiter une carence hormonale ?\nY a-t-il des traitements naturels ?\nQuels sont les effets secondaires des traitements ?\nQuand envisager une intervention chirurgicale ?",
"url": "https://questionsmedicales.fr/mesh/D010905#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hormones hypothalamiques hypophysotropes inhibitrices",
"description": "Quelles complications peuvent survenir ?\nComment les déséquilibres affectent-ils la santé mentale ?\nY a-t-il des risques cardiovasculaires ?\nQuels impacts sur la fertilité ?\nComment les hormones affectent-elles le métabolisme ?",
"url": "https://questionsmedicales.fr/mesh/D010905#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hormones hypothalamiques hypophysotropes inhibitrices",
"description": "Quels facteurs augmentent le risque d'hormones déséquilibrées ?\nLe surpoids influence-t-il les hormones ?\nY a-t-il un lien avec les maladies chroniques ?\nLes antécédents familiaux jouent-ils un rôle ?\nComment le mode de vie influence-t-il les hormones ?",
"url": "https://questionsmedicales.fr/mesh/D010905#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une insuffisance hormonale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins mesurant les niveaux hormonaux sont effectués."
}
},
{
"@type": "Question",
"name": "Quels examens pour évaluer l'hypothalamus ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM cérébrale est souvent utilisée pour visualiser l'hypothalamus."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un déséquilibre hormonal ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, changements d'humeur, et variations de poids peuvent indiquer un déséquilibre."
}
},
{
"@type": "Question",
"name": "Comment évaluer la fonction hypophysaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de stimulation hormonale peuvent être réalisés pour évaluer la fonction."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sanguins sont importants ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de prolactine et de cortisol sont des marqueurs clés à surveiller."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un excès d'hormones inhibitrices ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue, l'anxiété et des troubles du sommeil peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une carence hormonale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent la dépression, la prise de poids et la perte de libido."
}
},
{
"@type": "Question",
"name": "Quels effets sur le métabolisme ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un déséquilibre hormonal peut entraîner des troubles métaboliques et une obésité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les femmes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les irrégularités menstruelles et les bouffées de chaleur sont fréquentes."
}
},
{
"@type": "Question",
"name": "Quels symptômes chez les enfants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Retard de croissance et troubles de la puberté peuvent être observés."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déséquilibres hormonaux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain avec une alimentation équilibrée et de l'exercice aide."
}
},
{
"@type": "Question",
"name": "Y a-t-il des examens préventifs recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des bilans hormonaux réguliers peuvent aider à détecter des déséquilibres précocement."
}
},
{
"@type": "Question",
"name": "Quels facteurs de stress à éviter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Réduire le stress par des techniques de relaxation peut prévenir des déséquilibres."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle les hormones ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en nutriments peut soutenir l'équilibre hormonal."
}
},
{
"@type": "Question",
"name": "Comment le sommeil affecte-t-il les hormones ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un sommeil de qualité est crucial pour la régulation hormonale et le bien-être général."
}
},
{
"@type": "Question",
"name": "Quels traitements pour l'excès d'hormones inhibitrices ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les agonistes de la dopamine peuvent être prescrits."
}
},
{
"@type": "Question",
"name": "Comment traiter une carence hormonale ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies de remplacement hormonal sont souvent utilisées pour traiter la carence."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes comme le gattilier peuvent aider à réguler les hormones."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des maux de tête et des vertiges."
}
},
{
"@type": "Question",
"name": "Quand envisager une intervention chirurgicale ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une chirurgie peut être nécessaire en cas de tumeur hypophysaire ou d'anomalies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'infertilité et les troubles métaboliques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Comment les déséquilibres affectent-ils la santé mentale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent entraîner des troubles de l'humeur, comme la dépression et l'anxiété."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques cardiovasculaires ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres hormonaux peuvent augmenter le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels impacts sur la fertilité ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les déséquilibres hormonaux peuvent causer des problèmes d'ovulation et d'infertilité."
}
},
{
"@type": "Question",
"name": "Comment les hormones affectent-elles le métabolisme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un déséquilibre hormonal peut entraîner des troubles métaboliques, comme l'obésité."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'hormones déséquilibrées ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, le stress, et une mauvaise alimentation sont des facteurs de risque importants."
}
},
{
"@type": "Question",
"name": "Le surpoids influence-t-il les hormones ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le surpoids peut perturber l'équilibre hormonal et aggraver les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien avec les maladies chroniques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies chroniques, comme le diabète, peuvent affecter l'équilibre hormonal."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles hormonaux peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il les hormones ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire et le tabagisme peuvent perturber l'équilibre hormonal."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 10/02/2026
Contenu vérifié selon les dernières recommandations médicales
9 publications dans cette catégorie
Affiliations :
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center, Miami, FL 33125, USA.
Comprehensive Cancer Center, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Division of Hematology/Oncology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Department of Pathology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
8 publications dans cette catégorie
Affiliations :
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center, Miami, FL 33125, USA.
7 publications dans cette catégorie
Affiliations :
School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA.
6 publications dans cette catégorie
Affiliations :
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, 10126 Turin, Italy.
5 publications dans cette catégorie
Affiliations :
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, 10126 Turin, Italy.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
5 publications dans cette catégorie
Affiliations :
Department of Pharmacy, G. d'Annunzio University of Chieti-Pescara, 66100 Chieti, Italy.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
5 publications dans cette catégorie
Affiliations :
Department of Pharmacy, G. d'Annunzio University of Chieti-Pescara, 66100 Chieti, Italy.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
5 publications dans cette catégorie
Affiliations :
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center, Miami, FL 33125, USA.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
4 publications dans cette catégorie
Affiliations :
Department of Pharmacy, G. d'Annunzio University of Chieti-Pescara, 66013 Chieti, Italy. Electronic address: lucia.recinella@unich.it.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
4 publications dans cette catégorie
Affiliations :
Department of Pharmacy, G. d'Annunzio University of Chieti-Pescara, 66013 Chieti, Italy. Electronic address: annalisa.chiavaroli@unich.it.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
4 publications dans cette catégorie
Affiliations :
Department of Pharmacy, G. d'Annunzio University of Chieti-Pescara, 66013 Chieti, Italy. Electronic address: giustino.orlando@unich.it.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
4 publications dans cette catégorie
Affiliations :
Department of Pharmacy, G. d'Annunzio University of Chieti-Pescara, 66013 Chieti, Italy. Electronic address: claudio.ferrante@unich.it.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacy, G. d'Annunzio University of Chieti-Pescara, 66013 Chieti, Italy. Electronic address: veschi@unich.it.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
3 publications dans cette catégorie
Affiliations :
Department of Medicine and Ageing Sciences, G. d'Annunzio University of Chieti-Pescara, 66013 Chieti, Italy. Electronic address: valentina.divalerio@unich.it.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
2 publications dans cette catégorie
Affiliations :
Division of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, 10126 Turin, Italy.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
2 publications dans cette catégorie
Affiliations :
Department of Poultry and Aquaculture, Institute of Animal Sciences, Agricultural Research Organization, Volcani Center, Rishon Letziyon 7505101, Israel.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
2 publications dans cette catégorie
Affiliations :
School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
2 publications dans cette catégorie
Affiliations :
School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, USA.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
2 publications dans cette catégorie
Affiliations :
School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, USA.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
2 publications dans cette catégorie
Affiliations :
Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti-Pescara, 66013 Chieti, Italy; Center for Advanced Studies and Technology (CAST), G. d'Annunzio University of Chieti-Pescara, 66013 Chieti, Italy. Electronic address: rossano.lattanzio@unich.it.
Publications dans "Hormones hypothalamiques hypophysotropes inhibitrices" :
Growth hormone-releasing hormone (GHRH) has been widely shown to stimulate growth hormone (GH) production via binding to GHRH receptor GHRHR in various species of vertebrates, but information regardin...
Corticotropin-releasing hormone (CRH) is known for its crucial role in the stress response system, which could induce pituitary adrenocorticotropic hormone (ACTH) secretion to promote glucocorticoid r...
Pituitary apoplexy is a potentially fatal clinical condition that results from pituitary infarction due to ischemia or hemorrhage. We present a case of a 53-year-old female patient with a history of r...
The hypothalamic hormone growth hormone-releasing hormone (GHRH), in addition to promoting the synthesis and release of growth hormone (GH), stimulates the proliferation of human normal and malignant ...
Pituitary adenomas are a type of of the most frequent intracranial tumors. These tumors can extend outside the sella, but very rarely originate ectopically to the sellar region. A 71-year-old patient ...
GHRH is a neuropeptide associated with a diverse variety of activities in human physiology and immune responses. The present study reviews the latest information on the involvement of GHRH in the immu...
The growth hormone (GH)-releasing peptide-2 (GHRP-2) test is relatively safe among endocrine stimulation tests for the elderly. We investigated whether anterior pituitary function in elderly patients ...
Sixty-five elderly patients aged 65 years and older with non-functioning pituitary neuroendocrine tumor (PitNET) who underwent pituitary surgery and preoperative endocrine stimulation tests were class...
Thirty-two patients were assigned to the GH normal group and 33 to the GH deficiency group. The cortisol and adrenocorticotropic hormone (ACTH) results in the corticotropin-releasing hormone test were...
The present study indicated that adrenocortical function was significantly correlated with GH response to the GHRP-2 test in elderly patients before pituitary surgery. For elderly patients with non-fu...
The hypothalamic peptide growth hormone-releasing hormone (GHRH) stimulates the secretion of growth hormone (GH) from the pituitary through binding and activation of the pituitary type of GHRH recepto...
Luteinizing hormone-releasing hormone (LHRH) agonists are believed to have higher cardiovascular risk relative to gonadotropin-releasing hormone (GnRH) antagonists. However, previous studies have not ...
We performed a retrospective analysis of data in the Decision Resources Group (now Clarivate) Real World Evidence repository, which represents >300 million US patients from 1991 to 2020 across all US ...
A total of 45,059 men with prostate cancer treated with ADT were analyzed. Overall, the risks of MACE and all-cause mortality were slightly lower in the first year after ADT initiation compared to sub...
The adjusted incidence of MACE was higher for men treated with the GnRH antagonist compared to the LHRH agonists. The demographic and risk factors with the greatest impact on MACE risk were higher age...
Pituitary tumors (PTs) represent about 10% of all intracranial tumors, and most are benign. However, some PTs exhibit continued growth despite multimodal therapies. Although temozolomide (TMZ), an alk...